Skip to main content

Closed

KLRA: Kailera Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

5thpctl

Volume

0.59×avg

Market Cap

2.19BUSD

P/E Ratio

-13.4TTM

Div Yield

-ann

Kailera Therapeutics, Inc.

KLRANASDAQ Global Select·USD·Closed

Kailera Therapeutics, Inc.

KLRANASDAQ·USD·Closed

$16.94

−0.65%

$16.94

−$0.11 (0.65%)

52W Range

5thpctl

Volume

0.59×avg

Mkt Cap

2.19BUSD

P/E

-13.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings